phase readout
saveNCT03222492: Brentuximab Vedotin for Systemic Sclerosis
COMPLETEDupdated just now
community read0 votes
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc
view source ↗
comments(0)
5-min edit window · permanent after that